Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacotherapy to Enhance Weight Loss After Sleeve Gastrectomy
NCT03603080Phase 4Terminated
- Sponsor
- Hartford Hospital
- Start
- Mar 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin and topiramate in obesity (2 arms), sponsored by Hartford Hospital. Primary endpoint: Percent Total Body Weight Loss (%TWL) at 6 months. Started Mar 2019; status: terminated.
02
Drugs
metformintopiramate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03603080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03603080.